Cargando…

Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study

OBJECTIVES: Pharmacy assistants are often the first point of contact for patients presenting in community pharmacies. The current role of pharmacy assistants in the supply of asthma-reliever medications (short-acting β-agonists) was identified as a barrier to appropriate guideline-based care. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Watkins, Kim, Trevenen, Michelle, Murray, Kevin, Kendall, Peter A, Schneider, Carl R, Clifford, Rhonda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013480/
https://www.ncbi.nlm.nih.gov/pubmed/27580836
http://dx.doi.org/10.1136/bmjopen-2016-012369
_version_ 1782452174340489216
author Watkins, Kim
Trevenen, Michelle
Murray, Kevin
Kendall, Peter A
Schneider, Carl R
Clifford, Rhonda
author_facet Watkins, Kim
Trevenen, Michelle
Murray, Kevin
Kendall, Peter A
Schneider, Carl R
Clifford, Rhonda
author_sort Watkins, Kim
collection PubMed
description OBJECTIVES: Pharmacy assistants are often the first point of contact for patients presenting in community pharmacies. The current role of pharmacy assistants in the supply of asthma-reliever medications (short-acting β-agonists) was identified as a barrier to appropriate guideline-based care. The aim of this research was to devise and evaluate a team-based intervention to formalise the role of pharmacy assistants and to improve asthma guideline-based care in community pharmacy. DESIGN: A controlled pre-post intervention study was conducted in 336 metropolitan pharmacies located in Perth, Western Australia. Pharmacies were stratified into 2 groups (187 intervention and 149 control) based on known confounders for asthma control. The intervention was designed using a common-sense approach and resources developed included a checklist, videos and web page. Delivery was via workshops (25 pharmacies) or academic detailing (162 pharmacies). Pharmacy practice was assessed preintervention and postintervention via covert simulated patient methodology. Primary outcome measures included patient medical referral, device use demonstration and counselling, internal referral and/or direct involvement of a pharmacist in consultations. RESULTS: There was a significant increase in patient medical referral in intervention pharmacies from 32% to 47% (p=0.0007) from preintervention to postintervention, while control pharmacies showed a non-significant decrease from 50% to 44% (p=0.22). Device counselling was not routinely carried out at any stage or in any cohort of this research and no significant changes in internal referral were observed. CONCLUSIONS: Increases in medical referral indicate that asthma guideline compliance can be improved in community pharmacy if implementation employs a team-based approach and involves pharmacy assistants. However, results were variable and the intervention did not improve practice related to device counselling or internal referral/pharmacist involvement. Undertaking more workshops may have improved results. Guideline implementation in community pharmacy should consider the role of pharmacy assistants and how to overcome logistical barriers to pharmacy participation in implementation activities.
format Online
Article
Text
id pubmed-5013480
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50134802016-09-12 Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study Watkins, Kim Trevenen, Michelle Murray, Kevin Kendall, Peter A Schneider, Carl R Clifford, Rhonda BMJ Open Evidence Based Practice OBJECTIVES: Pharmacy assistants are often the first point of contact for patients presenting in community pharmacies. The current role of pharmacy assistants in the supply of asthma-reliever medications (short-acting β-agonists) was identified as a barrier to appropriate guideline-based care. The aim of this research was to devise and evaluate a team-based intervention to formalise the role of pharmacy assistants and to improve asthma guideline-based care in community pharmacy. DESIGN: A controlled pre-post intervention study was conducted in 336 metropolitan pharmacies located in Perth, Western Australia. Pharmacies were stratified into 2 groups (187 intervention and 149 control) based on known confounders for asthma control. The intervention was designed using a common-sense approach and resources developed included a checklist, videos and web page. Delivery was via workshops (25 pharmacies) or academic detailing (162 pharmacies). Pharmacy practice was assessed preintervention and postintervention via covert simulated patient methodology. Primary outcome measures included patient medical referral, device use demonstration and counselling, internal referral and/or direct involvement of a pharmacist in consultations. RESULTS: There was a significant increase in patient medical referral in intervention pharmacies from 32% to 47% (p=0.0007) from preintervention to postintervention, while control pharmacies showed a non-significant decrease from 50% to 44% (p=0.22). Device counselling was not routinely carried out at any stage or in any cohort of this research and no significant changes in internal referral were observed. CONCLUSIONS: Increases in medical referral indicate that asthma guideline compliance can be improved in community pharmacy if implementation employs a team-based approach and involves pharmacy assistants. However, results were variable and the intervention did not improve practice related to device counselling or internal referral/pharmacist involvement. Undertaking more workshops may have improved results. Guideline implementation in community pharmacy should consider the role of pharmacy assistants and how to overcome logistical barriers to pharmacy participation in implementation activities. BMJ Publishing Group 2016-08-31 /pmc/articles/PMC5013480/ /pubmed/27580836 http://dx.doi.org/10.1136/bmjopen-2016-012369 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Evidence Based Practice
Watkins, Kim
Trevenen, Michelle
Murray, Kevin
Kendall, Peter A
Schneider, Carl R
Clifford, Rhonda
Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study
title Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study
title_full Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study
title_fullStr Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study
title_full_unstemmed Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study
title_short Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study
title_sort implementation of asthma guidelines to west australian community pharmacies: an exploratory, quasi-experimental study
topic Evidence Based Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013480/
https://www.ncbi.nlm.nih.gov/pubmed/27580836
http://dx.doi.org/10.1136/bmjopen-2016-012369
work_keys_str_mv AT watkinskim implementationofasthmaguidelinestowestaustraliancommunitypharmaciesanexploratoryquasiexperimentalstudy
AT trevenenmichelle implementationofasthmaguidelinestowestaustraliancommunitypharmaciesanexploratoryquasiexperimentalstudy
AT murraykevin implementationofasthmaguidelinestowestaustraliancommunitypharmaciesanexploratoryquasiexperimentalstudy
AT kendallpetera implementationofasthmaguidelinestowestaustraliancommunitypharmaciesanexploratoryquasiexperimentalstudy
AT schneidercarlr implementationofasthmaguidelinestowestaustraliancommunitypharmaciesanexploratoryquasiexperimentalstudy
AT cliffordrhonda implementationofasthmaguidelinestowestaustraliancommunitypharmaciesanexploratoryquasiexperimentalstudy